GlassScriptPhysician profile
Albert A Nemcek
NPI 1013926153
$889.34
in general payments reported to CMS, 2019-2025
10 companies · $52.87 in 2025
The $52.87 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $200 · 2021: $13.67 · 2022: $96.22 · 2023: $73.63 · 2024: $310 · 2025: $52.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $217.51 | 2020-2024 | |
| Siemens Medical Solutions USA, INC. | $167.63 | 2024 | |
| Bard Peripheral Vascular, INC. | $155.11 | 2019-2022 | |
| Heartflow, INC. | $146.85 | 2023-2025 | Ffrct |
| Medtronic, INC. | $62.13 | 2021-2022 | |
| Cook Medical LLC | $38.50 | 2020-2024 | Beacon Tip Torcon Nb |
| Terumo Medical Corporation | $38.48 | 2020-2024 | Angio-Seal, Glidewire, Navicross |
| Penumbra, INC. | $31.04 | 2023-2024 | Penumbra System, Indigo System |
| W. L. Gore & Associates, INC. | $19.95 | 2025 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
| Covidien LP | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Nemcek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.